Utama › Kanser Perut › Pennsylvania › Philadelphia
Kajian klinikal Kanser Perut di Philadelphia, PA
15 kajian untuk Kanser Perut sedang mencari peserta di lokasi dalam dan sekitar Philadelphia (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Mengambil pesertaSukarelawan sihat dialu-alukan
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi jauh
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi jauh
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Mengambil pesertaFasa 2/3
- Alliance Cancer Specialists, PC, Wynnewood · 7 mi jauh
- Alliance Cancer Specialists, PC, Media · 12 mi jauh
- Alliance Cancer Specialists, PC, Horsham · 16 mi jauh
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Mengambil peserta
- Fox Chase Cancer Center - Philadelphia, Philadelphia
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Mengambil pesertaFasa 1
- Fox Chase Cancer Center, Philadelphia
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Mengambil pesertaFasa 3
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Mengambil pesertaFasa 3
- Research Site, Philadelphia
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
CTNNA1 Familial Expansion Study
Mengambil pesertaKajian pemerhatian
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Mengambil pesertaFasa 1/2
- University of Pennsylvania, Philadelphia
Adaptive Radiation for Abdominopelvic Metastases
Mengambil pesertaFasa 1
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Philadelphia
Kajian Kanser Perut di bandar lain
- Houston, TX42 kajian
- Boston, MA32 kajian
- New York City, NY31 kajian
- Nashville, TN28 kajian
- Baldwin Park, CA22 kajian
- Los Angeles, CA22 kajian
- Arlington, VA20 kajian
- Dallas, TX19 kajian
- San Antonio, TX19 kajian
- St. Louis, MO18 kajian
- Grand Rapids, MI18 kajian
- Washington, DC16 kajian
Kajian lain di Philadelphia
- Kanser (semua jenis)59 kajian
- Kanser Payudara56 kajian
- Kanser Paru-paru Bukan Sel Kecil51 kajian
- Kanser Metastatik46 kajian
- Kanser Prostat44 kajian
- Kanser Kolorektal44 kajian
- Kanser Ovari44 kajian
- Kanser Paru-paru36 kajian
- Leukemia Mieloid Akut34 kajian
- Kegagalan Jantung31 kajian
- Kanser Endometrium28 kajian
- Depresi26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.